Epigenomics troubleshooting
Resolve peak calling failures, low signal quality, differential analysis issues, and methylation calling errors.
This page helps you diagnose the common failure modes in epigenomics analysis — peak calling that returns nothing, low FRiP and other signal-quality problems, differential analysis with too few or too many significant regions, sparse methylation calls and missing DMRs, and BAM upload or timeout errors.
Epigenomics troubleshooting
No peaks called from ATAC-seq data
Symptom: Peak calling returns zero or very few peaks.
Fixes:
- Check your BAM file quality. Low read counts (<10 million unique reads) may not provide sufficient signal for peak calling
- Verify the BAM file is sorted and indexed. Unsorted BAMs will produce incorrect results
- Ensure duplicates are marked. PCR duplicates inflate signal at random loci and reduce effective coverage
- Try a different
peak_caller(macs2,hmmratac, orgenrich) — sensitivity varies by algorithm - Check that the correct genome assembly is specified. A mismatch between BAM alignment reference and the
genomeparameter (hg38ormm10) causes failures - If FRiP is below 0.05, the experiment likely has insufficient Tn5 insertion signal
Very low FRiP score
Symptom: FRiP is below 0.1 for ATAC-seq or below 0.05 for ChIP-seq.
Fixes:
- Low FRiP indicates high background relative to signal. This is typically an experimental rather than computational issue
- For ATAC-seq: check cell count (50,000-100,000 recommended), Tn5 concentration, and lysis conditions
- For ChIP-seq: check antibody quality, immunoprecipitation efficiency, and input DNA amount
- Mitochondrial reads inflate ATAC-seq background; filter them out of the BAM before upload — the tool does not expose a mitochondrial-filtering parameter
- Verify that duplicate removal was performed. High duplication rates reduce effective library complexity
ChIP-seq peaks look wrong with broad marks
Symptom: H3K27me3 or H3K36me3 peaks are fragmented into many small narrow peaks instead of broad domains.
Fixes:
- Set
peak_caller: "sicer2". The defaultmacs3is tuned for sharp signals and will fragment broad domains - See the inputs table for recommended peak callers by histone mark
Differential analysis returns no significant regions
Symptom: No regions pass the differential result's FDR threshold (0.05 by default).
Fixes:
- Ensure you have sufficient biological replicates. With only 2 replicates, statistical power is limited and subtle changes will not reach significance
- Verify that the peak files and metadata CSV assign samples to the correct conditions. Swapped labels produce random fold changes
- Check for batch effects. If treatment and control were processed on different days or with different protocols, batch variation may overwhelm biological signal
- Try the other differential
method(diffbindvsdeseq2) — they use different statistical models - The absence of significant results may be biologically real -- not all treatments cause epigenomic changes
Differential analysis shows excessive significant regions
Symptom: Thousands of regions are significant, which seems biologically implausible.
Fixes:
- Check for batch effects or sample swap between conditions
- Verify that the peak files for each condition are complete and correctly labeled in the metadata CSV
- Look at the fold change distribution. If most changes are small and in one direction, there may be a global shift rather than region-specific changes
Methylation calling returns very few sites
Symptom: Far fewer CpG sites than expected are reported.
Fixes:
- Check the
min_coverageparameter. The default of 5 reads filters out low-coverage sites. For shallow sequencing, reduce to 3 or 1 - Verify that the BAM file is from bisulfite sequencing (not standard WGS). Standard alignment produces zero methylation signal
- Ensure the correct reference genome is specified (
hg38ormm10). Genome mismatches cause alignment artifacts - For RRBS data, low genome-wide coverage is expected. RRBS enriches CpG islands and will report sites only in CpG-dense regions
- Check bisulfite conversion efficiency. Incomplete conversion (<95%) makes methylation calls unreliable
- Try the other calling
method(bismarkvsbsmap)
DMR detection finds no DMRs
Symptom: Zero differentially methylated regions detected.
Fixes:
- Try a different DMR
method(dmrseq,bsseq, ormethylkit) — sensitivity to subtle methylation changes varies by algorithm - Ensure sufficient replicates (2+ per condition)
- Check that the methylation files have adequate, consistent coverage across the region in all samples
- Verify that the methylation files and metadata CSV assign samples to the correct conditions
BAM file upload fails
Symptom: Error during BAM file upload or processing.
Fixes:
- BAM files must be valid, sorted, and indexed. Run
samtools quickcheck your_file.bamlocally to verify - Maximum file size depends on your plan. Very large BAM files (>50 GB) may need to be downsampled
- Ensure the BAI index file accompanies the BAM file. Some upload methods require both files
- Check that the BAM header contains valid sequence dictionary entries matching the selected genome
Analysis times out
Symptom: Peak calling or differential analysis fails with a timeout.
Fixes:
- Very large BAM files (>100 million reads) may exceed processing time limits. Downsample to 50-80 million reads for most analyses
- Reduce the number of conditions or replicates in differential analysis
- For methylation calling on WGBS, process individual chromosomes if whole-genome analysis times out
Getting help
If issues persist:
- Check the tool error message for specific suggestions
- Verify your BAM file quality using
samtools flagstatandsamtools idxstats - Try a smaller test BAM file to confirm the tool is working
- Describe the issue to Ivy
Read next
Was this page helpful?
Epigenomics quickstart
Step-by-step workflows for ATAC-seq peak calling, ChIP-seq analysis, differential accessibility, and methylation profiling.
Metagenomics on the platform
Taxonomic classification, community profiling, diversity analysis, and differential abundance tools for microbiome and metagenomic studies.